-70.3%
MRNA vs AVAV
+33.5%
-103.8%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -5.4% | +2.0% | -2.5% |
| 7D | -10.1% | -3.2% | -6.9% | -9.6% |
| 30D | +126.7% | -25.6% | +152.3% | +138.1% |
| 3M | +184.1% | -20.2% | +204.4% | +193.4% |
| 6M | +143.3% | -38.1% | +181.3% | +159.1% |
| YTD | +359.9% | -41.8% | +401.6% | +385.3% |
| 1Y | +454.2% | -39.0% | +493.2% | +477.4% |
| 3Y | +26.0% | +24.1% | +1.9% | +11.1% |
| 5Y | -70.3% | +53.0% | -123.3% | -79.5% |
| All | -70.3% | +33.5% | -103.8% | -79.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling